O
Otto C. Boerman
Researcher at Radboud University Nijmegen
Publications - 358
Citations - 17532
Otto C. Boerman is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Radioimmunotherapy & In vivo. The author has an hindex of 66, co-authored 355 publications receiving 15882 citations. Previous affiliations of Otto C. Boerman include Radboud University Nijmegen Medical Centre.
Papers
More filters
Proceedings ArticleDOI
Multimodal anti-PSMA ligands for intra-operative tumor detection and targeted photodynamic therapy of PSMA-expressing tumors
Y. Derks,Dennis W. P. M. Löwik,Helene I. V. Amatdjais-Groenen,Gerben Franssen,A. Kip,Otto C. Boerman,Sandra Heskamp,S. Lütje +7 more
Pretargeted immunoPET for imaging human colonic cancer in a mouse model
Rafke Schoffelen,Gerben M. Franssen,Bill J. McBride,Jonathan A. Disselhorst,Robert M. Sharkey,Peter Laverman,Winette T. A. van der Graaf,Wim J.G. Oyen,David M. Goldenberg,Otto C. Boerman +9 more
Journal ArticleDOI
106 Characterization of human squamous cell head and neck carcinoma xenografts using 18F-FLT and 18F-MISO autoradiography and immunohistochemistry
Jan Bussink,E.G.C. Troost,Peter Laverman,Marielle E.P. Philippens,Jasper Lok,Otto C. Boerman,J.H.A.M. Kaanders,A.J. van der Kogel +7 more
Journal ArticleDOI
OP0075 Sensitive Spect/CT Imaging of Synovial Fap Expression after Anti-IL-22 Treatment in Experimental Arthritis
Debbie M. Roeleveld,T. van der Geest,Tapan K. Nayak,Christian Klein,Birgitte Walgreen,M. M. A. Helsen,Martin Hegen,Peter Laverman,Otto C. Boerman,Marije I. Koenders +9 more
TL;DR: It is demonstrated that IL-22 plays an important role in the development of experimental arthritis, and targeting this cytokine seems an attractive new strategy in RA treatment, and SPECT/CT imaging of the inflamed synovium using the labeled anti-FAP antibody 111In-DTPA-28H1 can be used to specifically monitor response to therapy in an objective and quantitative way.
Journal ArticleDOI
Bone Regenerative Properties of Injectable Calcium Phosphate/PLGA Cement in an Alveolar Bone Defect
R.P. Félix Lanao,Jan Willem M. Hoekstra,Joop G.C. Wolke,Sander C.G. Leeuwenburgh,Adelina S. Plachokova,Otto C. Boerman,Jeroen J.J.P. van den Beucken,John A. Jansen +7 more
TL;DR: It is concluded that injectable CPC-dense PLGA composites proved to be the most suitable material for a potential use as off the shelf material due to its good biocompatibility, enhanced degradability and subsequent bone formation.